Pascal Druzgala serves as Executive at ARYx Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Pascal Druzgala has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 17, 2009 involved transacting 8,982 shares valued at $0.
Pascal Druzgala currently holds 8,982 shares of ARYx Therapeutics, Inc. (ARYX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pascal Druzgala has been a net neutral trader of ARYX stock. They have purchased $0 and sold $0 worth of shares.
Pascal Druzgala's most recent insider trade was on Aug 17, 2009, when they sold 8,982 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 27, 2008 | ARYX | $0 | Other | 7,684 | $N/A | Discretionary |
| Oct 27, 2008 | ARYX | $0 | Other | 7,684 | $N/A | Discretionary |
| Nov 13, 2007 | ARYX | $0 | Conversion | 1,122 | $N/A | Discretionary |